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Ontario, L8S 4M1, CanadaABSTRACT The iron-transport glycoprotein transferrin has recently been shown to serve as a potent inhibitor of Ab self-
association. Although this novel, to our knowledge, inhibitory function of transferrin is of potential therapeutic interest for the
treatment of Alzheimer’s disease, the underlying mechanism is still not fully understood. Although it has been shown that the
Fe(III) sequestration by transferrin reduces oxidative damage and Ab aggregation, it is not clear whether transferrin is also
able to inhibit Ab self-association through direct binding of Ab. Here, using saturation transfer and off-resonance relaxation
NMR spectroscopy, we show that transferrin inhibits Ab aggregation also by preferentially binding Ab oligomers and outcompet-
ing Abmonomers that would otherwise cause the growth of the Ab oligomers into larger assemblies. This inhibitory mechanism
is different from the iron-sequestration model, but it is qualitatively similar to a mechanism previously proposed for the inhibition
of Ab self-association by another plasma and cerebrospinal fluid protein, i.e., human serum albumin. These results suggest that
Ab monomer competition through direct Ab oligomer binding might be a general strategy adopted by proteins in plasma and
cerebrospinal fluid to prevent Ab aggregation.INTRODUCTIONSeveral plasma and CSF proteins have recently emerged as
potent inhibitors of Ab aggregation (1–11). The inhibition
of Ab self-association by plasma proteins is exploited in
therapeutic approaches of AD that rely on the peripheral
sink hypothesis (1,10,12). According to this hypothesis,
agents that bind plasma Abwithout crossing the blood-brain
barrier function as a sink for the brain Ab and can therefore
be effectively exploited to sequester the latter in peripheral
tissues, minimizing the accumulation of Ab in the CNS
(1,10,12). The inhibition of Ab self-association by CSF
proteins is of potential therapeutic interest also because
low levels of these proteins have been linked to increased
odds of cognitive impairment (2,10,11,13).
Tf is one of the plasma and CSF proteins with significant
Ab self-association inhibitory potency (7,11). Tf is a
78 kDa glycoprotein with a concentration of 38 and
0.17 mM in plasma and CSF, respectively. Tf transports
iron by binding Fe(III) with a 1:2 Tf:Fe(III) stoichiometry
and high affinity (Kd ~10
21 M) (11). Fe(III) in its free
form is known to induce the generation of oxygen radicals,
which in turn stimulate the production of toxic Ab aggre-
gates (14). In addition, the toxicity of free iron has been
shown to arise also from the iron-induced stabilization of
toxic, soluble intermediate oligomers of Ab, which delays
the formation of allegedly less toxic well-ordered aggre-Submitted December 14, 2012, and accepted for publication March 26,
2013.
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Open access under CC BY-NC-ND license.gates (15). By binding Fe(III), Tf sequesters the ferric
ions in a relatively nonreactive and inert state, which
reduces both the oxidative damage and the stabilization
of toxic Ab oligomers caused by free iron. The Fe(III)
sequestration by Tf thus provides a viable mechanism to
explain the Ab self-association inhibitory function
observed for Tf (7,11). However, other plasma and CSF
proteins have been shown to inhibit Ab aggregation
through a different and more direct mechanism, which
does not necessarily rely on metal sequestration (1,4,5).
For instance, HSA inhibits Ab self-association by directly
binding Ab oligomers and outcompeting Ab monomers
that would otherwise cause the growth of the Ab oligomers
into larger assemblies (1,4,5). In the case of Tf, it is
currently not known whether this HSA-like direct inhibi-
tion mechanism applies or iron sequestration is the only
mechanism for inhibiting Ab aggregation through Tf.
Although iron sequestration by Tf is an effective mech-
anism to inhibit Ab self-association, here we hypothesize
that additional inhibitory mechanisms should also be taken
into consideration when explaining the effect of Tf on Ab
oligomerization. To test this hypothesis, we have investi-
gated how Tf affects the self-association of the Ab
(12–28) peptide, which includes the central hydrophobic
core of Ab and is known to serve as a reproducible model
system for soluble Ab oligomers (1,4,5,16,17). Using a
combination of NMR techniques, which include STD
(18) and ORR (19–22), we show that, similarly to HSA,
Tf preferentially binds Ab (12–28) oligomers and com-
petes with their interaction with monomeric Ab (12–28).
These results suggest that iron sequestration (23–26) is
not the only mechanism through which Tf inhibits Ab ag-
gregation and provide a new framework to interpret the
role of Tf in AD.http://dx.doi.org/10.1016/j.bpj.2013.03.065
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Peptide sample preparation
Ab (12–28) (þH3N-V12HHQKLVFFAEDVGSNK28-COO
) was purchased
from EZBiolab, Westfield, IN, as a lyophilized powder with a minimum pu-
rity of 96.5%. The purity and the molecular weights were checked through
HPLC and mass spectrometry by EZBiolab. Each experimental trial that
involved a comparison between Ab (12–28) solutions was based on the
same batch of peptides to avoid any bias due to potential sample variability.
For the NMR samples, a 50 mM deuterated (d3) sodium acetate buffer was
prepared from a mixture of deuterated acetic acid (d4) and sodium hydrox-
ide used to adjust the pH to 4.7. 10% D2O (Cambridge Isotopes, Andover,
MA) was added to the acetate buffer for NMR locking purposes. The buffer
was then subjected to a syringe-driven filtration unit with a pore size of 0.22
mm from Millipore (Etobicoke, ON). One-dimensional (1D) 1H-WG NMR
spectra of the buffer was acquired before its use for sample preparation to
confirm its purity. Lyophilized Ab (12–28) was dissolved in the original
vials to minimize peptide losses and left to stand on ice for 10–20 min until
the peptide was fully dissolved. The uniformly dissolved sample of Ab (12–
28) in 50 mM acetate-d3, 10% D2O at pH 4.7 was purified to its largely
monomeric form through filtration. Ultrafree 30 kDa filter units were
used to ensure minimal binding of the peptide. An Allegra 25R Centrifuge
was used and run at 4000 rpm and 4C for 5 min. Before sample filtration,
potential residual glycerol from the filter units was removed from the filter
through centrifugal washing with 50 mM deuterated (d3) sodium acetate
buffer for 5–7 cycles. Ab (12–28) samples were spun repeatedly with sta-
bilization every 5 min in ice to minimize the heating of the sample. After
filtration, aggregation was reintroduced in a controlled manner through
the addition of NaCl. The salt was added using aliquots from concentrated
stock solutions (1 and 5 M NaCl), which were added to the filtered Ab (12–
28) sample. All volumes added to the peptide samples were in the 1–15 mL
range, resulting in negligible dilution factors. The Ab (1–42) peptide sam-
ples were prepared as previously described (1,4).Protein sample preparation
Tf was purchased from Sigma-Aldrich, Oakville, ON, as lyophilized pow-
der of human serum Tf with >98% purity and 20–40% saturation with
ferric irons, similar to human serum. Human serum Tf is here referred as
Tf. 500 mM samples of Tf were prepared by dissolving a weighted amount
of the powder in 50 mM deuterated (d3) sodium acetate buffer, pH 4.7 with
90:10 doubly distilled H2O:D2O. After dissolving the protein in the acetate
buffer, the solution was kept on ice and/or refrigerated at þ4C. Typically,
the total protein solution volume added to the peptide samples was within
the range of 1–8 mL, again resulting in negligible dilution factors.NMR spectroscopy
All NMR data were collected at 293 K using either a Bruker Avance 600
MHz NMR spectrometer with a 5 mm inverse triple resonance multinuclear
TBI-Z probe or a Bruker Avance 700 MHz NMR with a TCI cryoProbe. All
1D 1H NMR spectra acquired were recorded with 128 scans, 32 dummy
scans, and a spectral width of 8389.26 Hz sampled with 4096 complex
points and a repetition delay of 1 s. The WG by gradient-tailored excitation
with a binomial 3-9-19 pulse train was applied to all pulse sequences used
throughout the analysis (21). The self-association of Ab (1–42) was moni-
tored though signal losses over time in a 1D 1H-WG NMR experiment
incorporating a 30 ms long SL pulse with 2.6 kHz strength before acquisi-
tion to suppress the residual protein signal. The 1D time-profiles for Ab
(1–42) were acquired at 600 MHz using 128 scans and 64 dummy scans.
STD experiments were used to monitor the effect of Tf on the aggregated
Ab (12–28) samples (1,5,18). To achieve on-resonance saturation, the car-
rier frequency of a Gaussian pulse train was applied to the valine methyl
group within the hydrophobic core region of the Ab peptide atBiophysical Journal 105(2) 473–480~0.75 ppm. Off-resonance saturation for the STR experiment was obtained
by saturating at 30 ppm, a region in which no specific 1H resonance
occurs for the samples studied here. The saturation transfer difference
spectra were obtained by subtracting on-resonance and off-resonance
spectra through phase cycling (19,20). The Gaussian pulse train consisted
of a sequence of 40 Gaussian-shaped pulses of 50 ms each, separated by
a 1 ms interpulse delay, resulting in total saturation time of ~2 s, which
was preceded by a 100 ms interscan delay. The strength of each saturating
Gaussian pulse was 110.23 Hz with a 1% truncation and 1000 digitization
points. A 30 ms SL pulse with strength of 2.5 kHz was applied to suppress
the residual protein signal in all STD and STR experiments. For the STD
experiment 128 scans and 8 dummy scans were acquired, which were
reduced to 32 scans and 32 dummy scans for the more sensitive STR
spectra. For each titration point two STR and four STD replica spectra
were collected. All STD and STR replicas were then added to increase
the S/N ratios. The errors for the STD/STR ratios were evaluated using
the individual STR and STD replicas and error propagation. Before data
acquisition for each protein titration point, STD experiments were pre-
formed on a filtered Ab (12–28) sample as well as on an aggregated Ab
(12–28) sample without protein to confirm sample stability. All 1D spectra
were processed using an exponential multiplication window function before
zero filling.
The 1H off-resonance nonselective relaxation rates (R35.5 ,ns) experi-
ments (ORR) were acquired at 700 MHz with an off-resonance trapezoidal
SL including two adiabatic pulses of 4 ms duration and applied at the angle
of 35.5 to ensure optimal NOE/ROE compensation in the spin-diffusion
limit (19,20). The total SL durations were 13 and 88 ms. The strengths of
the off-resonance and TOCSY SLs were 8.25 and 10 kHz, respectively.
The interscan delay between the end of the acquisition and the start of
the first adiabatic pulse was 2 s. The spectral widths for both dimensions
were 8389.26 Hz with 256 t1 and 1024 t2 complex points, respectively.
For each experiment, 16 scans and 128 dummy scans were employed. All
two-dimensional (2D) replica sets were coadded to increase the S/N ratios
and processed with Xwinnmr, Bruker) using a 90 phase-shifted squared
sine-bell window function for both dimensions before zero filling. The
2D crosspeak intensities were measured with Sparky 3.111 (22) by
Gaussian line fitting using the fit peak heights. The standard deviation of
the differences in fit heights between two copies was used to estimate the
error of the individual spectra. The error of the sum was scaled up propor-
tionally to the square root of the total number of scans. For all residues, the
Ha,i-HN,i crosspeaks were used for the ORR data analysis, with the excep-
tion of G25 and of the N-terminal V12. G25 was omitted from the analysis
due to the overlap of its degenerate Ha protons, whereas for V12, the Ha,12-
HMe,12 crosspeak was used to probe Ha relaxation rates. The nonselective
ORR rates in s1 were computed from the experimental fit heights though
the equation:
R35:5;ns ¼ ln ðfit height at 13 ms = fit height at 88 msÞð0:088 s 0:013 sÞ :
(1)
The nonselective off-resonance relaxation rates calculated based on the pre-
vious equation are within error of the ORR rates calculated using fivedifferent SL times. The measured rates and the related errors were then
normalized with respect to the maximum observed rate.Inductively coupled plasma experiments
The ICP technique was used to detect trace metals in the buffer solution
used for the NMR experiments. The ICP data were acquired using a Perkin
Elmer ELAN 6100 ICP-MS set at the detection wavelength of 259.94 nm
for analysis of solution-based iron contamination following a pretreatment
with 1% nitric acid.
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To probe how Tf inhibits Ab self-association, we initially
acquired 1D NMR spectra of Ab (12–28) in the absence
and presence of Tf (Fig. 1). The self-association of Ab
(12–28) in acetate buffer has been shown to mimic in a sta-
ble and reproducible manner the early Ab soluble oligo-
mers, which are populated only transiently by longer Ab
constructs (1,4,5,16,17). The Ab (12–28) peptide in acetate
buffer is subject to a steady-state exchange between mono-
meric and oligomeric Ab (12–28) and this dynamic self-
association equilibrium is effectively monitored through
NMR line-broadening (5). For instance, narrow lines are
observed in the absence of salt for a filtered Ab (12–28)
sample, which is primarily monomeric (Fig. 1 a). However,
when 40 mM NaCl is added to promote self-association
through electrostatic screening (27), a significant line-
broadening is detected for the large majority of the Ab
(12–28) signals (Fig. 1 b). The salt-induced increase in line-
width is caused by the exchange between the monomeric
and oligomeric forms of Ab (12–28) (1,4,5).
It is notable that no detectable self-association was
observed for the filtered Ab (12–28) sample under our
experimental conditions and within the time frame of our
experiments (Fig. 1 a), indicating that iron traces possibly
present in our samples are not effective in promoting the
aggregation of Ab (12–28). This result is also supportedby chelation experiments (vide infra) and ICP analyses,
showing that the concentration of iron impurities within
our samples is minimal and below 36 nM. The line-broad-
ening observed for Ab (12–28) in Fig. 1 b is therefore not
expected to be caused by the residual free iron, but primarily
by the monomer/oligomer exchange. Nevertheless, when Tf
is added to the Ab (12–28) sample in substoichiometric
amounts, either before or after salt addition, a dramatic
line-narrowing effect is observed (Fig. 1, c and d), which
restores the Ab (12–28) line widths to values comparable
to those measured for the filtered Ab (12–28) before the
addition of salt (Fig. 1 a). No significant chemical shift
changes are detected upon addition of Tf (Fig. 1).
A possible explanation for the linewidth reduction
without significant chemical shift variations occurring
upon Tf addition (Fig. 1) is that under our experimental con-
ditions Tf binds selectively to the Ab (12–28) oligomers
rather than to the Ab (12–28) monomer (Fig. 2). The result-
ing Ab (12–28) oligomer/Tf complex inhibits the exchange
of Ab (12–28) polypeptide chains between the monomeric
and oligomeric forms of Ab (12–28), leading to the
observed line-narrowing effect of Tf (Fig. 1, d and c;
Fig. S3 in the Supporting Material). The model outlined in
Fig. 2 explains also why dramatic line-narrowing is obtained
even with minimal substoichiometric amounts of Tf (Fig. 1,
c and d). However, additional experiments are required to
further corroborate the proposed model. For instance, basedFIGURE 1 Monitoring the inhibition of Ab (12–
28) self-association by Tf using 1D NMR. 1D-
WG-NMR spectra of Ab (12–28) filtered with a
30 kDa C.O. filter before (A) and after (B) the addi-
tion of 40 mM NaCl. (C) Effect of the addition of
10 mM Tf, leading to narrow lines similar to the
filtered sample A. (D) Effect of the addition of Tf
before NaCl, resulting in line-narrowing compara-
ble to C. Data were collected at 293 K and 700
MHz with a Bruker TCI cryoprobe. The horizontal
axis reports the 1H chemical shift in ppm.
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FIGURE 2 Schematic representation of the proposed direct and indirect
mechanisms for the inhibition of Ab self-association by Tf. Dashed lines
indicate possible noncovalent interactions between Tf and the Ab peptide.
T-ended solid lines denote inhibition. Tf binds preferentially with Ab olig-
omers, inhibiting the addition of further Ab monomers to the preexisting
Ab oligomers (direct mechanism). Tf also binds Fe(III) inhibiting the
Fe(III) inducible oxidative damage, which would otherwise promote the
formation of Ab aggregates, as indicated by the nonhorizontal arrow.
This iron-mediated inhibitory mechanism is denoted here as the indirect
mechanism or the iron-sequestration mechanism. Monomeric Ab inhibits
iron inducible oxidative damage (14).
476 Raditsis et al.on the data of Fig. 1 it is not possible to rule out the
possibility that the absence of Ab (12–28) monomer/Tf in-
teractions is simply due to the saturation of Tf by Ab (12–
28) oligomers as opposed to the lack of any significant affin-
ity of Tf for monomeric Ab (12–28). To further probe this
possibility, we designed a negative control experiment in
which Tf was added to a sample with filtered and diluted
Ab (12–28) in the absence of salt to ensure that Ab (12–
28) is primarily monomeric without potentially Tf-satu-
rating Ab (12–28) oligomers (Fig. S1). No significantBiophysical Journal 105(2) 473–480changes were observed for Ab (12–28) in either line widths
or chemical shifts upon the addition of Tf (Fig. S1), indi-
cating that indeed under our experimental conditions Tf
does not significantly bind monomeric Ab (12–28) and con-
firming our initial hypothesis (Fig. 2).
The selectivity of Tf for Ab (12–28) oligomeric species
was further confirmed by a positive control experiment in
which the fraction of NMR-undetectable Ab (12–28) oligo-
mers is effectively increased by increasing the NaCl concen-
tration from 40 to 60 mM (Fig. S2 b). As expected, in the
presence of 60 mM NaCl further line-broadening is
observed (Fig. S2 b) relative to the spectra acquired with
40 mM NaCl (Fig. 1 b), confirming a higher population of
Ab (12–28) oligomers. Based on the model of Fig. 2, we
would then expect that, upon addition of Tf, line-narrowing
should be observed due to the inhibition of monomer/olig-
omer exchange, but without restoring the intensity of the
NMR signal to the values measured before addition of
salt, due to the sequestration of a large fraction of monomer
into NMR-undetectable oligomers. Our data fully support
this prediction (Fig. S2 c). When Tf is added to the Ab
(12–28) sample with 60 mM NaCl, line-narrowing is
observed (Fig. S2 c), similar to Fig. 1. However, unlike
Fig. 1, Tf is unable to restore the intensity of the NMR signal
to the levels observed in the absence of salt (Fig. S2 a),
despite the line-narrowing effect of Tf (Fig. S2 c). These
observations further confirm the model of Fig. 2.
A specific implication of the proposed model (Fig. 2) is
that Tf effectively screens the Ab (12–28) oligomers from
the monomeric form of Ab (12–28). Based on the model
of Fig. 2, we therefore expect that the NMR line-narrowing
effect of Tf should be comparable to that obtained through
physical removal of the Ab (12–28) oligomers, for instance
through filtration in the absence of salt. A stringent test of
this prediction is provided by NMR experiments that quan-
titatively measure the linewidth change. One of these NMR
methods is the 2D ORR experiment with a tilt angle of 35.5
(19,20). Fig. 3 a indicates that the residue-specific ORR
rates of the filtered sample without NaCl and of the sampleFIGURE 3 Tf addition and filtration have com-
parable effects on the ORR rates of Ab (12–28).
(A) Residue-specific normalized ORR rates for
filtered 650 mM Ab (12–28) (:), 650 mM Ab
(12–28) with 40 mM NaCl (,) and 650 mM Ab
with both 40 mM NaCl and 10 mM Tf (>). (B)
Correlation between the changes in normalized
ORR rates caused by Tf (vertical axis) and those
caused by filtration (horizontal axis). The 2D
ORR data were recorded at 293 K and at 700
MHz using a Bruker TCI cryoprobe.
FIGURE 4 1D STD monitored isotherm for the Ab (12–28) self-associa-
tion inhibition by Tf. Tf was titrated into a solution of salt-aggregated 650
mM Ab (12–28) and 1D STD and STR spectra were acquired at 293 K and
at 600 MHz using a Bruker TBI-Z probe. Experimental data points are
reported as circles, whereas the solid line was obtained through nonlinear
fitting of the equation fþ (1-f)*Kd,app./(Kd,app.þ [Tf]), where f is the fraction
of Ab (12–28) oligomers that are not Tf-binding competent, [Tf] is the con-
centration of free Tf and Kd,app. is an apparent average dissociation constant
for the complexes between Tf and the other Ab (12–28) oligomers (1). The
dashed and dot-dashed lines were obtained using the same equation but by
varying the Kd,app. value obtained through nonlinear curve fitting (i.e.,
43 nM, assuming that the product of the total concentration of Tf-binding
competent Ab oligomers and of the ratio of the number of Tf molecules
bound per Ab oligomer versus the number of Ab oligomers bound per Tf
molecule is% 5 nM. If this product is >5 nM, the Kd,app. values reported
in the figure become just an upper limit to the best fit Kd,app. values). We
also assumed that all Tf molecules bind to equivalent and independent bind-
ing sites (Scatchard-like model) (1). The latter assumption reflects the
simplest model that fits the experimental data. The dotted line defines the
IC50 for the inhibition of Ab (12–28) self-association inhibition by Tf.
Ab Oligomerization Inhibition by Transferrin 477with both 40 mM NaCl and Tf are systematically reduced
relative to those of the sample with 40 mMNaCl but without
Tf. This result was expected based on the linewidth changesreported in Fig. 1. However, the quantitative ORR analysis
also shows that the changes in relaxation caused by Tf addi-
tion are comparable and correlated with those caused by the
physical elimination of the Ab (12–28) oligomers through
filtration (Fig. 3 b), confirming the oligomer screening func-
tion of Tf as predicted by the model shown in Fig. 2.
Another NMR method to quantitatively monitor the Ab
(12–28) oligomer screening effect exerted by Tf is the
STD NMR experiment (5,18). Fig. 4 reports the relative
1D STD changes observed for Ab (12–28) as a function
of the Tf concentration, showing a clear dose-response
pattern with distinct binding and saturation regions. The
plateau observed in the saturation region indicates that the
interaction between the Ab (12–28) oligomers and Tf is spe-
cific, whereas the binding region points to an IC50% 0.1 mM
for the inhibition of Ab (12–28) self-association by Tf under
our experimental conditions (Fig. 4).
To further test the hypothesis that the inhibition of Ab
(12–28) self-association by Tf observed under our experi-
mental conditions is not due to iron sequestration, we
acquired STD spectra in the presence of a metal chelator,
i.e., EDTA (Fig. 5). Fig. 5 shows that EDTA does not affect
the STD magnitude of the salt aggregated Ab (12–28) sam-
ple, indicating that under our experimental conditions iron
sequestration is not a viable mechanism for inhibiting Ab
(12–28) self-association. However, when Tf is added, either
before or after the addition of EDTA, the STD magnitude is
decreased to values comparable to those observed for the
filtered Ab (12–28) sample in the absence of salt, which is
mainly monomeric (Fig. 5). Overall, the results of Fig. 5
confirm that under our experimental conditions the mecha-
nism for the inhibition of Ab (12–28) self-association by
Tf does not rely on iron sequestration (Fig. 2).
The model for the Ab self-association inhibitory function
of Tf proposed in Fig. 2 based on Ab (12–28), also explains
the effect of Tf on the longer Ab (1–42) peptide (Fig. 6).FIGURE 5 1D STD monitored chelation experi-
ments show that Tf can inhibit Ab (12–28) self-
association even without iron sequestration.
Normalized STD/STR ratios measured under mul-
tiple experimental conditions, as reported in the
figure. Compounds were added in the order listed.
All data were collected at 293 K and at 700 MHz
using a Bruker TCI cryoprobe.
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FIGURE 6 Effect of chelation and Tf addition on the aggregation profile
of Ab (1–42) as monitored by 1D NMR signal losses over time. (A) 1D
NMR integral versus time for Ab (1–42), Ab (1–42) þ 1 mM EDTA,
and Ab (1–42) þ 50 mM Tf. Symbols for the actual experimental data
are reported in the figure legend. The experimental data were fitted using
the offset decaying exponential: a  e-bt þ c, where t is in hours and the
a–c parameters were obtained through nonlinear curve-fitting. The fitted
curves are shown as a sequence of open circles. After ~20 h most of the
1D NMR signal of Ab (1–42) is lost due to the formation of high-MW
NMR-undetectable aggregates. A similar pattern is observed in the pres-
ence of the EDTA chelator, however Tf considerably reduces the degree
of signal loss. (B and C) 1D NMR spectra of Ab (1–42) at the first sampled
time point in the absence and presence of Tf. Tf does not cause detectable
changes in the 1D NMR spectra, consistent with the absence of significant
binding between Tf and monomeric Ab (1–42). The horizontal axis reports
the 1H chemical shift in ppm.
478 Raditsis et al.Due to the transient nature of the STD-detectable Ab (1–42)
oligomers, the Ab (1–42) self-association was monitored
through losses in the 1D NMR signal of Ab (1–42), which
results from the formation of high molecular weight
(MW) NMR-undetectable aggregates. Fig. 6 a shows the
time profile for the 1D NMR signal of Ab (1–42). In the
absence of Tf,>60% of the original NMR signal is lost after
24 h (Fig. 6 a). Upon addition of 1 mM of the EDTA
chelator only minimal and almost marginal changes in the
Ab (1–42) time profile are detected (Fig. 6 a), indicating
that free iron sequestration is not an effective mechanism
to inhibit Ab (1–42) aggregation under our experimental
conditions, likely due to the low iron content of our solu-
tions. However, upon addition of substoichiometric amounts
of Tf a significant enhancement of the 1D NMR signal is
observed (Fig. 6 a), confirming that Tf is able to inhibit
Ab (1–42) self-association through a mechanism that doesBiophysical Journal 105(2) 473–480not necessarily rely on iron sequestration. This mechanism
does not involve binding of Tf to Ab (1–42) monomers, as
no change in chemical shift for Ab (1–42) was observed
upon the Tf addition (Fig. 6, b and c). Therefore, we
conclude that the Ab (1–42) data presented in Fig. 6 fully
support the model outlined in Fig. 2 and originally based
on the Ab (12–28) system.DISCUSSION
Our data on the Ab (12–28) peptide consistently indicate
that Tf is able to inhibit Ab self-association even without
iron sequestration. This inhibitory effect is supported
by multiple independent experiments, i.e., Tf-dependent
changes in linewidth (Fig. 1 and Fig. S2), in ORR rates
(Fig. 3), in STD/STR ratios (Fig. 4 and Fig. 5). Overall,
our data are fully consistent with a model in which Tf selec-
tively binds Ab oligomers rather than monomers (Fig. 2).
Upon binding to Tf, the Ab oligomers are screened from
the Abmonomers hindering the growth of the Ab oligomers
into larger assemblies (Fig. 2). Under our experimental con-
ditions, the affinity of Tf for the Ab (12–28) oligomers
appears to be in the sub-mM range, with IC50 values not
greater than the plasma concentration of Tf (~38 mM) (7).
Previously, an IC50 value of 30 mM was reported for the
inhibition of biotin-labeled Ab (1–40) incorporation into
immobilized Ab (1–42) polymers by Tf (7). This IC50 value
is in between the plasma and CSF concentrations of Tf
and is significantly higher than the IC50 reported here
(Fig. 4), but it is possible that variations in IC50 values
are due to differences in experimental conditions and/or
Ab peptide used. Specifically, the data of Fig. 1 and Figs.
3–5 were acquired on the Ab (12–28) peptide and different
Ab constructs may behave differently. However, the 1D
intensity versus time profiles measured for Ab (1–42)
(Fig. 6) suggest that the model proposed for Ab (12–28)
may apply, at least at a qualitative level, also to longer
Ab peptides.
The model of Ab self-association inhibition by Tf
emerging from this study (Fig. 2) is qualitatively similar
to the mechanism previously proposed for the inhibition
of Ab aggregation by another plasma protein, i.e., HSA
(1,4,5). Furthermore, in the case of HSA a marked Ab
oligomer versus monomer selectivity was observed and,
similar to Tf, the Ab oligomer – HSA complexes compete
with the addition of Ab monomers to preexisting Ab
oligomers (1,4,5). It is therefore possible that the Ab
oligomer-binding model proposed in Fig. 2 represents a
general Ab self-association inhibitory strategy shared
by multiple plasma proteins. In addition, other Ab self-
association inhibitory agents have been shown to act
through a similar mechanism. For instance, inorganic nano-
particles such as quantum dots bind to Ab oligomers or
fibers and interfere with the conversion of monomers into
fibers (28).
Ab Oligomerization Inhibition by Transferrin 479The Ab oligomer-binding model is however markedly
different from a previously proposed mechanism for the pro-
tective action of Tf against Ab fibrillization (Fig. 2) (11).
According to the previous model, Tf inhibits Ab aggrega-
tion by sequestering free iron, which would otherwise
induce the production of toxic Ab aggregates either by pro-
moting the formation of oxygen-free radicals and/or by
delaying the formation of ordered and less toxic Ab fibrils
(Fig. 2) (11,15,23–26). The iron-sequestration mechanism
still remains a viable strategy for the inhibition of Ab fibril-
lization by Tf because Fe, together with Cu and Zn, is likely
linked to pathological events in AD (29), here we show that
other more direct mechanisms should be considered as well
(Fig. 2). Furthermore, monomeric Ab is known to inhibit
neuronal cell death caused by Fe(II) and Fe(III) and there-
fore the absence of detectable interactions between Tf and
Ab monomers suggests that even in the presence of Tf the
monomeric form of Ab can still serve as an antioxidant
against metal-induced oxidative damage (Fig. 2) (14). It is
also possible that Tf enhances the concentration of mono-
meric Ab by interfering with its binding to Ab oligomers,
thus indirectly potentiating the antioxidant effect of mono-
meric Ab. Overall, we conclude that the mechanism pro-
posed here for the inhibition of Ab self-association by Tf,
i.e., formation of Ab oligomer:Tf complexes and conse-
quent screening of Ab oligomers from Ab monomers
(Fig. 2), is distinct from the previously elucidated iron-
sequestration inhibitory models (Fig. 2) and should be taken
into consideration when rationalizing the role of Tf in Ab
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